Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice-Reference-Cited by-同舟云学术

Reasons to be testing: the dawn of complex molecular profiling in routine oncology practice

Published:2019-11 Issue:11 Volume:30 Page:1691-1694
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Beer Philip A.,Cooke Susanna L.,Chang David K.,Biankin Andrew V.

Funder

Wellcome Trust Senior Investigator

Scottish Genome Partnership SEHHD-CSO

MRC

Glasgow Molecular Pathology Node

Howat Foundation. Cancer Research UK

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz392/30314092/mdz392.pdf

Reference21 articles.

1. Economic impact of next-generation sequencing versus single-gene testing to detect genomic alterations in metastatic non–small-cell lung cancer using a decision analytic model;Pennell;JCO Precis Oncol,2019

2. Cost effectiveness of multigene panel sequencing for patients with advanced non-small-cell lung cancer;Steuten;JCO Clin Cancer Inform,2019

3. Precision pathology as part of precision medicine: are we optimizing patients’ interests in prioritizing use of limited tissue samples?;McCall;JCO Precis Oncol,2019

4. Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review;Merker;J Clin Oncol,2018

5. A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers;Sabari;J Natl Cancer Inst,2019

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study;Japanese Journal of Clinical Oncology;2024-01-25

2. Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors;World Journal of Pediatrics;2023-03-13

3. Treatment of pancreatic cancer in 2022;Cambridge Prisms: Precision Medicine;2023

4. Bridging the implementation gap: delivering complex genomic analysis for routine cancer care;Annals of Oncology;2022-09

5. Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With MEK Mutation and PIK3CA Amplification Achieved by Dual Trametinib and Metformin Therapy;JCO Precision Oncology;2022-05